SCHEMBL8953704

SCHEMBL8953704

CCOC(=O)c1ccnc(C(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JMJD6 Q6NYC1 5/20 0.53
PIK3CA P42336 1/20 0.51
CA12 O43570 3/20 0.49
CA1 P00915 3/20 0.49
CA2 P00918 3/20 0.49
CA7 P43166 3/20 0.49
CA9 Q16790 3/20 0.49
CA14 Q9ULX7 3/20 0.49
KDM5B Q9UGL1 2/20 0.46
ESR1 P03372 1/20 0.45
ESR2 Q92731 1/20 0.45
KDM5A P29375 1/20 0.44
KDM5C P41229 1/20 0.44
KDM4C Q9H3R0 1/20 0.44
HSD17B2 P37059 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAOA P21397 1/20 0.44
IMPDH2 P12268 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22912529 0.87 JMJD6 (0.50) JMJD6PIK3CACA12CA1CA2
SCHEMBL12136063 0.86 PIK3CA (0.53) JMJD6PIK3CACA12CA1CA2
SCHEMBL15994051 0.85 JMJD6 (0.51) JMJD6PIK3CACA12CA1CA2
SCHEMBL5364217 0.85 JMJD6 (0.51) JMJD6PIK3CACA12CA1CA2
SCHEMBL17143953 0.82 JMJD6 (0.50) JMJD6PIK3CACA12CA1CA2
SCHEMBL8953772 0.82 KDM4E (0.57) JMJD6CA12CA1CA2CA7
SCHEMBL30171421 0.80 JMJD6 (0.76) JMJD6PIK3CACA12CA1CA2
SCHEMBL811785 0.80 JMJD6 (0.76) JMJD6PIK3CACA12CA1CA2
SCHEMBL363249 0.80 JMJD6 (0.58) JMJD6PIK3CACA12CA1CA2
SCHEMBL6300868 0.79 JMJD6 (0.49) JMJD6LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188085-B2 Antifungal agents MERCK SHARP & DOHME CORP. (US) 2012-05-29 US disclosed
US-20100113439-A1 Antifungal agents MERCK & CO., INC. (US) 2010-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113439-A1 Antifungal agents GMDS, GBA3, UGGT1 JMJD6 3078/4885PIK3CA 881/4885CA12 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.